Literature DB >> 22209125

The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms.

Divya Mehta1, Carina Quast, Peter A Fasching, Anna Seifert, Franziska Voigt, Matthias W Beckmann, Florian Faschingbauer, Pascal Burger, Arif B Ekici, Johannes Kornhuber, Elisabeth B Binder, Tamme W Goecke.   

Abstract

BACKGROUND: Maternal depression during the peripartum period has an incidence of about 13%. Individuals with specific genetic predispositions are more vulnerable to stressful life events suggesting that exploration of gene-environmental pathways might facilitate the identification of risk factors for peripartum depression. The aim of this study was to evaluate the influence of stressful life events in combination with the serotonin transporter gene 5-HTTLPR polymorphism on peripartum depressive symptoms.
METHODS: In a non-psychiatric cohort of 419 Caucasians, the severity of depression was assessed prospectively during pregnancy (3rd trimester) and the postpartum period (2-3 days and 6-8 months) using the Edinburgh Postnatal Depression Scale. Satisfaction with the partner and exposure to negative life events were evaluated using self-report questionnaires and the genotype of the 5-HTTLPR was assessed. Repeated measures generalized linear models were used to investigate the gene-environment interaction on depressive symptoms across late pregnancy and the postpartum period.
RESULTS: The 5-HTTLPR S-allele carrier status predicted late postpartum depressive symptom severity only in the presence of negative life events. This interaction was not observed for depressive symptoms during the 3rd trimester or the early postpartum. In addition, S-allele carrier status increased the negative effects of dissatisfaction with the current partner on depressive symptoms in the late postpartum period.
CONCLUSIONS: In this non-psychiatric cohort, the 5-HTTLPR interacts with both lifetime and current stressors to influence depressive symptoms in the late post partum period. These findings could have clinical implications by allowing identification of women at higher risk for developing postpartum depressive symptoms.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209125     DOI: 10.1016/j.jad.2011.11.042

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  22 in total

1.  Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.

Authors:  Lauren Osborne; Makena Clive; Mary Kimmel; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Jennifer Judy; Samantha Meilman; Aviva Braier; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Fernando Goes; Jennifer L Payne; Elisabeth B Binder; Zachary Kaminsky
Journal:  Neuropsychopharmacology       Date:  2015-10-27       Impact factor: 7.853

2.  Oxytocin receptor DNA methylation in postpartum depression.

Authors:  Mary Kimmel; Makena Clive; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Lauren M Osborne; Elisabeth Binder; Jennifer L Payne; Zachary Kaminsky
Journal:  Psychoneuroendocrinology       Date:  2016-04-08       Impact factor: 4.905

Review 3.  Postpartum depression: A systematic review of the genetics involved.

Authors:  Tiago Castro E Couto; Mayra Yara Martins Brancaglion; António Alvim-Soares; Lafaiete Moreira; Frederico Duarte Garcia; Rodrigo Nicolato; Regina Amélia Lopes P Aguiar; Henrique Vitor Leite; Humberto Corrêa
Journal:  World J Psychiatry       Date:  2015-03-22

4.  DNA methylation biomarkers prospectively predict both antenatal and postpartum depression.

Authors:  Jennifer L Payne; Lauren M Osborne; Olivia Cox; John Kelly; Samantha Meilman; Ilenna Jones; Winston Grenier; Karen Clark; Evelyn Ross; Rachel McGinn; Pathik D Wadhwa; Sonja Entringer; Anne L Dunlop; Anna K Knight; Alicia K Smith; Claudia Buss; Zachary A Kaminsky
Journal:  Psychiatry Res       Date:  2019-11-27       Impact factor: 3.222

Review 5.  Biological and psychosocial predictors of postpartum depression: systematic review and call for integration.

Authors:  Ilona S Yim; Lynlee R Tanner Stapleton; Christine M Guardino; Jennifer Hahn-Holbrook; Christine Dunkel Schetter
Journal:  Annu Rev Clin Psychol       Date:  2015       Impact factor: 18.561

6.  Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria.

Authors:  Jutta Pretscher; Matthias Ruebner; Arif B Ekici; Melanie Rödl; Hanna Huebner; Judith Schwitulla; Adriana Titzmann; Charlotte Hartwig; Matthias W Beckmann; Peter A Fasching; Michael O Schneider; Eva Schwenke
Journal:  Arch Gynecol Obstet       Date:  2020-09-30       Impact factor: 2.344

7.  Genetic variants in the glucocorticoid pathway genes and birth weight.

Authors:  Michael O Schneider; Theresa Hübner; Jutta Pretscher; Tamme W Goecke; Judith Schwitulla; Lothar Häberle; Johannes Kornhuber; Arif B Ekici; Matthias W Beckmann; Peter A Fasching; Eva Schwenke
Journal:  Arch Gynecol Obstet       Date:  2020-09-04       Impact factor: 2.344

8.  Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.

Authors:  Patrick MacDonald Fisher; Camilla Borgsted Larsen; Vincent Beliveau; Susanne Henningsson; Anja Pinborg; Klaus Kähler Holst; Peter Steen Jensen; Claus Svarer; Hartwig Roman Siebner; Gitte Moos Knudsen; Vibe Gedsoe Frokjaer
Journal:  Neuropsychopharmacology       Date:  2016-09-21       Impact factor: 7.853

9.  The dynamic serotonin system of the maternal brain.

Authors:  Joseph S Lonstein
Journal:  Arch Womens Ment Health       Date:  2018-07-21       Impact factor: 3.633

10.  Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot study.

Authors:  Julia K Pinsonneault; Danielle Sullivan; Wolfgang Sadee; Claudio N Soares; Elizabeth Hampson; Meir Steiner
Journal:  Arch Womens Ment Health       Date:  2013-08-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.